# Roflumilast

NDC: 31722-623
Generic name: Roflumilast
Labeler / Manufacturer: Camber Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20221015

FDA application: ANDA208213

## Active ingredients

- ROFLUMILAST: 500 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"31722-623"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=31722-623
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f25a0230-3cf6-4366-bebe-0ea5ff8de5ab